Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome | Zendy

Orrin Devinsky | Zendy; J. Helen Cross | Zendy; Linda Laux | Zendy; Eric D. Marsh | Zendy; Ian Miller | Zendy; Rima Nabbout | Zendy; Ingrid E. Scheffer | Zendy; Elizabeth A. Thiele | Zendy; Stephen Wright | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome

Author(s) -

Orrin Devinsky,

J. Helen Cross,

Linda Laux,

Eric D. Marsh,

Ian Miller,

Rima Nabbout,

Ingrid E. Scheffer,

Elizabeth A. Thiele,

Stephen Wright

Publication year - 2017

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1611618

Subject(s) - cannabidiol , dravet syndrome , medicine , placebo , anesthesia , epilepsy , confidence interval , odds ratio , lennox–gastaut syndrome , pediatrics , cannabis , psychiatry , alternative medicine , pathology

The Dravet syndrome is a complex childhood epilepsy disorder that is associated with drug-resistant seizures and a high mortality rate. We studied cannabidiol for the treatment of drug-resistant seizures in the Dravet syndrome.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research